Market Share of Global Polycystic Ovarian Syndrome Treatment Industry
The major market players are focusing on symptomatic treatments; several have their drugs in clinical trials but are not approved for marketing. There is a growing focus on surgeries, and many medical devices are focused on the same. Some of the major players in the market are Bayer AG, Ferring BV, Merck KGaA, Novartis, Pfizer, Takeda, and Teva Pharmaceutical Industries Limited, among others.
Polycystic Ovarian Syndrome (PCOS) Treatment Market Leaders
Pfizer Inc.
Teva Pharmaceutical Industries Limited
Novartis International AG
Takeda Pharmaceutical Company Limited
Bayer AG
*Disclaimer: Major Players sorted in no particular order